Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Antimicrobial Chemotherapy|November 1, 1990
Pharmacokinetics of cefodizime administered intravenously as a single-dose (1.0 and 2.0 g) to healthy adult volunteersA Bryskier, T Procyk, D Tremblay, et al.
Pathologie-Biologie|May 1, 1984
[HPLC study of the inhibition of enterobacterial cephalosporinases by cefmenoxime]A Pechinot, J M Duez, A Bryskier, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1990
The pharmacokinetics of cefodizime following intravenous and intramuscular administration of a single dose of 1.0 gA Bryskier, T Procyk, D Tremblay, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2001
The bactericidal activities of HMR 3004, HMR 3647 and erythromycin against gram-positive bacilli and development of resistanceR Fernández-Roblas, R Calvo, J Esteban, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1997
Bactericidal activity of cefodizime on Enterobacteriaceae in an in-vitro model simulating plasma pharmacokinetics in humansA Péchinot, C Neuwirth, A Bryskier, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|August 1, 1984
Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporinM O Husson, D Izard, A Bryskier, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 1998
Use of ketolides in combination with other drugs to treat experimental toxoplasmosisF G Araujo, A A Khan, A Bryskier, et al.
The American Journal of Medicine|December 21, 1984
Pharmacokinetic study of cefmenoxime (SCE 1365-CMX) in healthy adultsJ B Fourtillan, A Bryskier, A Mignot, et al.
Pageof 12